Items where Author is "Oxford COVID Vaccine Trial Group"

Article

Feng, S ORCID: 0000-0001-7855-0991, Phillips, DJ ORCID: 0000-0003-0686-5091, White, T, Sayal, H, Aley, PK, Bibi, S, Dold, C, Fuskova, M ORCID: 0000-0002-2146-4299, Gilbert, SC ORCID: 0000-0002-6823-9750, Hirsch, I, Humphries, HE, Jepson, B, Kelly, EJ ORCID: 0000-0002-6988-8576, Plested, E, Shoemaker, K, Thomas, KM ORCID: 0000-0002-0348-654X, Vekemans, J, Villafana, TL, Lambe, T ORCID: 0000-0001-7711-897X, Pollard, AJ ORCID: 0000-0001-7361-719X et al (2021) Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection. Nature Medicine, 27 (11). pp. 2032-2040. ISSN 1078-8956

Frater, J ORCID: 0000-0001-7163-7277, Ewer, KJ ORCID: 0000-0001-9827-9836, Ogbe, A, Pace, M, Adele, S ORCID: 0000-0003-4458-1751, Adland, E, Alagaratnam, J, Aley, PK, Ali, M, Ansari, MA ORCID: 0000-0003-2790-8353, Bara, A, Bittaye, M, Broadhead, S, Brown, A, Brown, H, Cappuccini, F, Cooney, E, Dejnirattisai, W, Dold, C, Fairhead, C et al (2021) Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial. The lancet. HIV, 8 (8). e474-e485. ISSN 2405-4704